Impact of a Tele-rehabilitation Program on People With Multiple Sclerosis: A Multicenter, Randomized, Single-blind Study.

Running, not recruitingNot a drug-phase studyMS (type not specified)NCT07178834

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Telerehab

What it measured

Main measures

  • Adverse events

    From enrollment to the end of treatment in week 8

    FatigueWalking and mobilityPainSafety

Other measures (4)

  • Multiple Sclerosis Quality of Life 54

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

    Quality of life (reported by participants)
  • 10 meters walking test

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

    Walking and mobility
  • 6 minute walking test

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

    Walking and mobility
  • Berg Balance Scale

    (T1) baseline, (T2) after the 8 week, (T3) at 16 week.

    Walking and mobility

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Patients diagnosed with multiple sclerosis confirmed using the 2017 McDonald criteria. * Patients who have the technological means to conduct online sessions and the autonomy to do so. * Patients with cognitive capacity that allows them to sign the informed consent form. * Patients with an internet connection and a device compatible with the Rehub tele-rehabilitation platform (desktop computer, laptop, or tablet). * EDSS level less than or equal to 6.5.

Exclusion criteria

* Participants who are currently undergoing RHB at a center. * Participants who have undergone RHB during the two months prior to the start of the program. * Patients with physical or mental comorbidities that may limit their participation in the rehabilitation program.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The goal of this clinical trial is to assessing safety and the occurrence of adverse effects during tele-rehabilitation (TRHB) in people with multiple sclerosis with an EDSS score of 6.5 or lower. The main questions it aims to answer are: * Intervention using TRHB is considered safe and without adverse effects. * Intervention using TRHB has a high degree of self-adherence, an impact on physical activity levels and self-efficacy in exercise, and a positive effect on quality of life, mood, and perception of fatigue. Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations. Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.

Papers

Loading reviews and guidelines…

History

    1. Started

      Feb 2025

    2. Main results due

      Sept 2025

    3. Finished

      Sept 2025

    Assembled by software from public sources.